DK2114130T3 - Dyremodel for ADHD - Google Patents

Dyremodel for ADHD

Info

Publication number
DK2114130T3
DK2114130T3 DK08701838.8T DK08701838T DK2114130T3 DK 2114130 T3 DK2114130 T3 DK 2114130T3 DK 08701838 T DK08701838 T DK 08701838T DK 2114130 T3 DK2114130 T3 DK 2114130T3
Authority
DK
Denmark
Prior art keywords
adhd
animal model
conditions
animal
model
Prior art date
Application number
DK08701838.8T
Other languages
English (en)
Inventor
Susan Clare Stanford
Hugh Gurling
Steven Hunt
Original Assignee
Ucl Business Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Plc filed Critical Ucl Business Plc
Application granted granted Critical
Publication of DK2114130T3 publication Critical patent/DK2114130T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DK08701838.8T 2007-01-17 2008-01-17 Dyremodel for ADHD DK2114130T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0700894.9A GB0700894D0 (en) 2007-01-17 2007-01-17 Animal model
PCT/GB2008/000160 WO2008087419A2 (en) 2007-01-17 2008-01-17 Animal model for adhd

Publications (1)

Publication Number Publication Date
DK2114130T3 true DK2114130T3 (da) 2011-11-14

Family

ID=37810095

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08701838.8T DK2114130T3 (da) 2007-01-17 2008-01-17 Dyremodel for ADHD

Country Status (7)

Country Link
US (1) US20100169994A1 (da)
EP (1) EP2114130B1 (da)
AT (1) ATE516704T1 (da)
DK (1) DK2114130T3 (da)
ES (1) ES2370210T3 (da)
GB (1) GB0700894D0 (da)
WO (1) WO2008087419A2 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191342B1 (en) * 1998-12-02 2001-02-20 Lg Chemical Ltd. Transgenic mice expressing the HIK-ras 4B chimeric gene
GB9924513D0 (en) * 1999-10-15 1999-12-15 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ES2370210T3 (es) 2011-12-13
WO2008087419A2 (en) 2008-07-24
EP2114130B1 (en) 2011-07-20
ATE516704T1 (de) 2011-08-15
US20100169994A1 (en) 2010-07-01
WO2008087419A3 (en) 2008-09-18
EP2114130A2 (en) 2009-11-11
GB0700894D0 (en) 2007-02-21

Similar Documents

Publication Publication Date Title
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
NL301145I2 (nl) Tirbanibulin
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
TR201901930T4 (tr) Topraktaki mikrobiyal aktivitenin geliştirilmesine yönelik bir yöntem.
EA200900970A1 (ru) Лечение нарушений дыхательной цепи с помощью соединений, имеющих активность эритропоэтина или тромбопоэтина
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
UY34280A (es) Nuevos compuestos que tienen actividad inhibidora frente a la daminoacido oxidasa.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
UY34039A (es) Compuestos fungicidas
EA200901653A1 (ru) ОПОСРЕДУЕМОЕ PHKi ИНГИБИРОВАНИЕ ЭКСПРЕССИИ АЛЬФА-EnaC
EA201171367A1 (ru) Винилиндазолильные соединения
BRPI0818732A2 (pt) Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
EA200701995A1 (ru) Способы уменьшения кальцификации
TN2010000096A1 (en) Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
TW200621254A (en) Method for the treatment of attention deficit hyperactivity disorder
UY33549A (es) Quinolil aminas como agentes inhibidores de las quinasas
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
EA201100920A1 (ru) Новые гербициды
ECSP14011792A (es) Inhibidores de iap
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.